Baxter International Inc (BAX)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$16.31

Buy

$17.29

arrow-down$-0.02 (-0.12%)

Prices updated at 01 Apr 2026, 09:03 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.

Income statement

20242025
10,636m11,244m
3,984m3,379m
439m177m
4.131.57
-649m-957m
1,116m766m
Sales, General and administrative2,967m2,890m
Interest expenses408m290m
Provision for income taxes37m395m
Operating expenses3,545m3,202m
Income before taxes-289m-505m
Net income available to common shareholders-649m-957m
-1.27-1.87
Net interest income-341m-238m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-1.27-1.87
Free cash flow per share0.7670.4483
Book value/share15.407314.0798
Debt equity ratio1.5245551.581987

Balance sheet

20242025
Current assets8,853m6,872m
Current liabilities6,511m2,970m
Total capital17,338m15,602m
Total debt13,449m9,780m
Total equity6,964m6,129m
Total non current liabilities--
Loans10,374m9,473m
Total assets25,782m20,055m
Total liabilities--
Cash and cash equivalents1,764m1,966m
Common stock511m514m

Cash flow

20242025
Cash at beginning of period3,198m2,414m
Cash dividends paid-590m-348m
559m323m
Investments (gains) losses-626m2,841m
2,414m1,968m
Net income--
1,019m845m
-460m-522m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.